Pharma Deals Review, Vol 2005, No 59 (2005)

Font Size:  Small  Medium  Large

IDM’s and Epimmune’s Merger Highlights Biotech Funding Difficulties

Business Review Editor

Abstract


Immuno-Designed Molecules entered into merger agreement with Epimmune to form a combined company to be named as IDM, Inc.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.